Status:
UNKNOWN
Eating vs Skipping Breakfast on Postprandial Hyperglycemia After Lunch and Dinner in T2D
Lead Sponsor:
Tel Aviv University
Conditions:
Breakfast
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
Background: Skipping breakfast and/or overeating at evening, has been associated in type 2 diabetic (T2D) individuals, with higher BMI, visceral adiposity, hyperlipidemia, increased overall postprandi...
Detailed Description
Background or Rationale Studies analyzing the postprandial glycemic response have shown that glucose tolerance display a clear diurnal variation with a progressive decline in carbohydrate tolerance to...
Eligibility Criteria
Inclusion
- T2D since \< 10 yrs, with HbA1c \> 7 % and BMI: 26-34 kg/m2.
- Only naïve or treated with oral antidiabetic drugs and with anti-hypertensive and lipid-lowering medication will be included.
- Those treated with insulin or GLP-1 analogs or having major liver, heart or kidney illnesses will be excluded.
Exclusion
- Type 1 DM, secondary DM, gestational DM
- Patients using insulin, TZDs
- Patients using corticosteroid, herb medication or other medications affecting glucose tolerance
- Renal dysfunction (Cr \> 1.5mg/dL)
- Hepatic dysfunction (LFT \> x 3UNL)
- Anemia (Hg \> 10g/dL)
- Ischemic heart disease, congestive heart failure
- Severe diabetic complication (CRF, CVA, PDR, gastroparesis)
- Infectious disease
- Malignancy
- Pregnant women
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02287103
Start Date
April 1 2015
End Date
November 1 2015
Last Update
June 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes Unit E. Wolfson Medical center
Holon, Tel Aviv, Israel, 58100